查找临床试验
已按「淀粉样变性」检索，对应国际通用词 amyloidosis
共找到 12 项正在招募的试验（在中国／港澳台设有中心）
数据更新于 11:18，每 5 分钟自动同步BCMA/CD3 Bispecific Antibody Treatment for Newly Diagnosed Amyloidosis
China
年龄 18 Years – 不限
Institute of Hematology & Blood Diseases Hospital, China
Clinical Study for AL-CM
China
年龄 18 Years – 80 Years
Second Affiliated Hospital, Zhejiang University, School of Medicine
Optimization Strategy of Carotid Artery Stenosis
China
年龄 18 Years – 不限
Peking Union Medical College Hospital
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
United States、Argentina、Australia、Austria、Belgium 等 12 国
年龄 18 Years – 85 Years
Alnylam Pharmaceuticals
Daratumumab, Bortezomib, Cyclophosphamide, and Dexamethasone Therapy for Patients with MIDD
China
年龄 18 Years – 不限
Peking University People's Hospital
A Study to Evaluate the Safety and Efficacy of SCTC21C in Combination With Bortezomib, Cyclophosphamide, and Dexamethasone in Patients With Newly Diagnosed Systemic Light-Chain Amyloidosis (NDSLCA)
China
年龄 18 Years – 不限
Sinocelltech Ltd.
Teclistamab in Previously Treated AL Amyloidosis
China
年龄 18 Years – 不限
Peking Union Medical College Hospital
Assessment of the Efficacy and Safety of Injectable TQB2934 (Subcutaneous Injection) in Systemic Light Chain Amyloidosis Patients
China
年龄 18 Years – 80 Years
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.
Sonrotoclax Plus Dexamethasone With or Without Daratumumab Regimen in Patients With t(11;14) Primary AL Amyloidosis
China
年龄 18 Years – 不限
Peking University People's Hospital
Prospective Study of Teclistamab in the Treatment of Systemic AL Amyloidosis
China
年龄 不限 – 不限
Peking University People's Hospital
Generative AI Impact on Rheumatoid Arthritis Complications Diagnosis
China
年龄 不限 – 不限
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
ConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis)
United States、Brazil、Bulgaria、Denmark、France 等 12 国
年龄 不限 – 不限
Alnylam Pharmaceuticals